SCPC Calls for Solutions that Protect Long-term Care Patients and Pharmacies as White House Announces Initial List for Medicare Drug Price Negotiations
Washington, D.C. (August 29, 2023) – The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the Biden administration’s announcement of the first 10 drugs selected for Medicare price negotiations, eight of which are heavily utilized by patients served by long-term care pharmacies.
“The Senior Care Pharmacy Coalition supports access to prescription drugs for all consumers, including the Medicare beneficiaries our members predominately serve. However, we must ensure that pharmacies – and long-term care pharmacies and the patients they serve, in particular – do not become collateral damage in any efforts to address rising medication costs,” stated Alan Rosenbloom, president and CEO of the Senior Care Pharmacy Coalition. “Long-term care patients and pharmacies will be severely and disproportionately impacted by these price negotiations, given that eight of the medications named by the Biden administration are heavily prescribed to patients in long-term care facilities. Moving forward, our policymakers must consider the important role of long-term care pharmacies in improving health outcomes for the Medicare population so as not to limit patient access to the medications and other important long-term care pharmacy services they rely on.”
Patients served by long-term care pharmacies, on average, are prescribed a higher number of medications by a higher number of providers, making the role of the pharmacist especially important in ensuring proper medication management.
Rosenbloom pointed out that insurance companies and pharmacy benefit managers (PBMs) – not pharmacies – are the major drivers of high drug costs and urged legislators to advance policies that will create more transparency between PBMs and Medicare Part D. Earlier this summer, SCPC applauded the Senate Finance Committee for passing legislation to curtail PBMs’ harmful actions.
LTC pharmacies lose money on most of the medicines they prescribe to patients, realizing a profit on just a small portion of the prescriptions they fill. Thus, the Biden administration’s decision to target eight medications heavily prescribed to the patients LTC pharmacies serve will have an immediate and detrimental impact on the long-term care pharmacy community.
“Our legislators and public officials should be reducing burdens on long-term care pharmacies, rather than making it more difficult and costly for them to serve their patients across the U.S.,” added Rosenbloom. “We must keep the focus on legislation that puts patients first and addresses some of the longstanding problems within our healthcare system – most notably, those with PBMs.”
###
About Senior Care Pharmacy Coalition
The Senior Care Pharmacy Coalition (SCPC) is the only national organization exclusively representing the interests of LTC pharmacies, representing 75% of the sector overall. Its members operate in all 50 states and serve 850,000 patients daily in skilled nursing and assisted living facilities across the country. Visit seniorcarepharmacies.org to learn more.
Recent Posts
-
Senior Care Pharmacy Coalition Applauds Chairman Comer and House Oversight Committee for Shedding Light on Harmful PBM Practices, Encourages Congress to Advance PBM Reform Legislation Heard Today in House Energy and Commerce Committee Health Subcommittee
The Senior Care Pharmacy Coalition (SCPC), the leading national voice for the long-term care pharmacy community, released a statement today regarding the House Oversight Committee’s hearing on pharmacy benefit managers.
-
Stuck in the middle, LTC pharmacies could be dangerously squeezed by drug price negotiations
Any lower drug prices that result from White House efforts to negotiate on behalf of Medicare beneficiaries may lead to short-term gains for nursing homes, but there also could be a steep price to pay in the long-term, experts warned this week. The Centers for Medicare & Medicaid Services on Tuesday announced the first 10 drugs covered by Medicare Part D that will be included in negotiations running through 2024. They are all commonly prescribed drugs that treat conditions ranging from diabetes to arthritis and heart failure.
-
Biden’s Plans to Reduce Cost of Medicare Drugs To Send Ripple Effects Through Nursing Home Industry
Following the Biden Administration’s bid this week to reduce the price of certain drugs – many of which are commonly used in nursing homes – experts are cautioning that the changes may negatively impact the bottomline of organizations in the sector. As Medicare Part D price negotiations for these drugs come into focus this week, the Senior Care Pharmacy Coalition (SCPC), for one, is warning that changes to Part D might cause “collateral damage” to long-term care pharmacies, the patients they serve and operator partners.
Stay in the Know
Get the latest news and updates on issues impacting the long-term pharmacy community.